RPMI-8226

Zellname

Beschreibung

Bestell-Nr.

Einheit

Preis, Euro

RPMI-8226

Humane Myelom Zell-Linie

300431

cryovial

265,00

RPMI-8226

Humane Myelom Zell-Linie

330431

vital

335,00



Designation:RPMI-8226
Depositor:Moore
Organism:Homo sapiens (human)
Age/Stage:61 years
Gender:male
Tissue:Blood
Morphology:lymphoblast
Celltype:Myeloma
Growth Properties:monolayer/suspension
Description:There is no evidence of heavy chain production (cytoplasmic or secreted).
Culture Medium:RPMI 1640 medium supplemented with 2 mM L-glutamine and 10% fetal bovine serum.
Subculturing:Cultures can be maintained by addition or replacement of fresh medium.Cultures can be established at 5 x 105 viable cells/ml. Maximum cell density at 1-2 x 106 cell/ml.
Freeze Medium:CM-1 (CLS Cell Lines Service)
Sterility:Tests for mycoplasma, bacteria and fungi were negative
Biosafety Level:1
Antigen Expression:HLA Aw19, B15, B37, Cw2
Isotype:lambda light chain
Isoenzymes:G6PD, A
Reverse Transcriptase:negative
Products:immunoglobulin light chain


References:

Matsuoka Y et al. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med. 125: 1246-1250, 1967.
Moore GE, Kitamura H. Cell line derived from patient with myeloma. N.Y. State J. Med. 68(15): 2054-2060, 1968.
Krueger RG et al. Tumor-associated antigens in human myeloma. J Natl Cancer Inst 56(4): 711-715, 1976.
Yu S et al. IN vitro actions on human cancer cells and the liquid chromatography-mass spectrometry/mass spectrometry fingerprint of phytochemicals in rice protein isolate. J Agric Food Chem 54(12): 4482-4492, 2006.
Lee KW et al. Direct role of NF-kappaB activation in Toll-like receptor-trigered HLA-DRA expression. Eur J Immunol 36(5): 1254-1266, 2006.

 

  Change language: eng        Diese Seite drucken   Sitemap   Kontakt  


 
top